Related references
Note: Only part of the references are listed.The extracellular matrix of hematopoietic stem cell niches q
Cornelia Lee-Thedieck et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition
Bing Z. Carter et al.
HAEMATOLOGICA (2022)
High-speed fluorescence image-enabled cell sorting
Daniel Schraivogel et al.
SCIENCE (2022)
In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia
Yongsheng Ruan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
Julia C. Gutjahr et al.
HAEMATOLOGICA (2021)
Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
Wittawat Chantkran et al.
CELL DEATH DISCOVERY (2021)
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study
Gautam Borthakur et al.
CANCER (2021)
Expression and role of fibroblast activation protein α in acute myeloid leukemia
Shuchong Mei et al.
ONCOLOGY REPORTS (2021)
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao et al.
MOLECULAR CANCER (2021)
Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy
Shiman Zuo et al.
CELL DEATH & DISEASE (2021)
Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts
Yuanyuan Li et al.
CANCER CELL INTERNATIONAL (2021)
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
Andrew M. K. Law et al.
FRONTIERS IN ONCOLOGY (2021)
Cross-tissue organization of the fibroblast lineage
Matthew B. Buechler et al.
NATURE (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes
Katerina E. Miari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Dongqing Yan et al.
BLOOD CANCER DISCOVERY (2021)
Extracellular matrix and its therapeutic potential for cancer treatment
Jiacheng Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support
Mitra Azadniv et al.
LEUKEMIA (2020)
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia
Eleni E. Ladikou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Origin and functional heterogeneity of fibroblasts
Valerie S. LeBleu et al.
FASEB JOURNAL (2020)
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia
Divij Verma et al.
LEUKEMIA (2020)
Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement
James W. Day et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
Ramprasad Ramakrishnan et al.
CELL REPORTS (2020)
Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches
Johanna Erbani et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia
Chengyun Pan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy
Dorian Forte et al.
CELL METABOLISM (2020)
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies
Venkateshwar Rao Gummadi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Stromal cells promote chemoresistance of acute myeloid leukemia cells via activation of the IL-6/STAT3/OXPHOS axis
Diyu Hou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
Annalisa Adamo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease
Giada Dal Collo et al.
STEM CELLS (2020)
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
Haydar Celik et al.
BLOOD ADVANCES (2020)
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Donia M. Moujalled et al.
LEUKEMIA (2019)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
Cassandra Ringuette Goulet et al.
BMC CANCER (2019)
Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy
Tongtong Chen et al.
LIFE SCIENCES (2019)
Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
Rongsheng Zhang et al.
CELL DEATH & DISEASE (2019)
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
Ninib Baryawno et al.
CELL (2019)
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Michael Steurer et al.
HAEMATOLOGICA (2019)
Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
Masaaki Murakami et al.
IMMUNITY (2019)
Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration
Richard Schaefer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Heterogeneity in refractory acute myeloid leukemia
Sachi Horibata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Concise Review: Mesenchymal Stem Cells: From Roots to Boost
Anna Andrzejewska et al.
STEM CELLS (2019)
Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
Xi-xi Li et al.
ONCOTARGETS AND THERAPY (2019)
Cancer-associated fibroblasts-heroes or villains?
Krystyna A. Gieniec et al.
BRITISH JOURNAL OF CANCER (2019)
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
Jin Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Mesenchymal stem cells: Cell therapy and regeneration potential
Christina Brown et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths
Samuel L. Wolock et al.
CELL REPORTS (2019)
Three-Dimensional Leukemia Co-Culture System for In Vitro High-Content Metabolomics Screening
Xiyuan Lu et al.
SLAS DISCOVERY (2019)
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Tianyi Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia
Vindhya Vijay et al.
LEUKEMIA RESEARCH (2019)
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic Syndrome (MDS) in Primary Human Bone Marrow Aspirates
Thomas J. Fountaine et al.
BLOOD (2019)
Combining CDK2/9 Inhibitor CYC065 with Venetoclax, a BCL2 Inhibitor, to Treat Patients with Relapsed or Refractory AML or MDS
Gautam M. Borthakur et al.
BLOOD (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
Francisco Caiado et al.
NATURE COMMUNICATIONS (2019)
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
Natasha S. Anstee et al.
CELL DEATH AND DIFFERENTIATION (2019)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
Stefanie Geyh et al.
HAEMATOLOGICA (2018)
The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment
Danielle G. Leuning et al.
SCIENTIFIC REPORTS (2018)
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
Stefanie Geyh et al.
HAEMATOLOGICA (2018)
Differentiation-based model of hematopoietic stem cell functions and lineage pathways
Thomas Hoefer et al.
BLOOD (2018)
A phase Ib/II study of BMS-813160, a CC chemokine receptor (CCR) 2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with advanced pancreatic or colorectal cancer
Dung Le et al.
CANCER RESEARCH (2018)
Hematopoietic stem cell and mesenchymal stem cell population size in bone marrow samples depends on patient's age and harvesting technique
Katja Rebolj et al.
CYTOTECHNOLOGY (2018)
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
Gabriela Flores-Lopez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Fibroblasts as a practical alternative to mesenchymal stem cells
Thomas E. Ichim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Haley E. Ramsey et al.
CANCER DISCOVERY (2018)
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
Eimear O'Reilly et al.
SCIENTIFIC REPORTS (2018)
Acute myeloid leukemia: 2019 update on risk-stratification and management
Elihu H. Estey
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Aditi Shastri et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival
Giulia Corradi et al.
STEM CELL RESEARCH & THERAPY (2018)
Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
Lucy V. Ireland et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
From haematopoietic stem cells to complex differentiation landscapes
Elisa Laurenti et al.
NATURE (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia
Amina M. Abdul-Aziz et al.
CANCER RESEARCH (2017)
Understanding the extracellular matrix in acute myeloid leukemia
Valerio Izzi et al.
HAEMATOLOGICA (2017)
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia
Zhihong Zeng et al.
HAEMATOLOGICA (2017)
A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche
Laura J. Bray et al.
HAEMATOLOGICA (2017)
Focal Adhesion Kinase as a Potential Target in AML and MDS
Bing Z. Carter et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report
Xin Long et al.
ONCOTARGET (2017)
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
Patricia Macanas-Pirard et al.
ONCOTARGET (2017)
Understanding the extracellular matrix in acute myeloid leukemia
Valerio Izzi et al.
HAEMATOLOGICA (2017)
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia
Zhihong Zeng et al.
HAEMATOLOGICA (2017)
A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche
Laura J. Bray et al.
HAEMATOLOGICA (2017)
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
Rafael Diaz de la Guardia et al.
STEM CELL REPORTS (2017)
Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal Lymphopoiesis
Juan Carlos Balandran et al.
FRONTIERS IN IMMUNOLOGY (2017)
Magnetically levitated mesenchymal stem cell spheroids cultured with a collagen gel maintain phenotype and quiescence
Natasha S. Lewis et al.
JOURNAL OF TISSUE ENGINEERING (2017)
The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
Patricia Macanas-Pirard et al.
PLOS ONE (2017)
Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance
Alexandra M. Stevens et al.
BLOOD ADVANCES (2017)
AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth
V. Lokesh Battula et al.
JCI INSIGHT (2017)
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Juliana Benito et al.
CLINICAL CANCER RESEARCH (2016)
The role of Eph/ephrin molecules in stromal-hematopoietic interactions
Thao M. Nguyen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy
Ruxanda Moschoi et al.
BLOOD (2016)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells
Yuanmei Zhai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias
Jae-Won Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
Hai Yi et al.
ONCOTARGET (2016)
Hypoxia and Hypoxia-inducible Factors in Leukemias
Margaux Deynoux et al.
FRONTIERS IN ONCOLOGY (2016)
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
Filar de la Puente et al.
BIOMATERIALS (2015)
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
Jerome Paggetti et al.
BLOOD (2015)
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
Carolina Schinke et al.
BLOOD (2015)
Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia
Xin Long et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia
Yu Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy
Heidrun Drolle et al.
LEUKEMIA RESEARCH (2015)
A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment
A-Reum Han et al.
ONCOLOGY REPORTS (2015)
Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
Xiaojin Li et al.
SCIENTIFIC REPORTS (2015)
Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow
Carmen Muniz et al.
STEM CELL RESEARCH & THERAPY (2015)
Hematopoietic Stem Cell-Derived Cancer-Associated Fibroblasts Are Novel Contributors to the Pro-Tumorigenic Microenvironment
Lindsay T. McDonald et al.
NEOPLASIA (2015)
Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27Kip1 axis
Ping Chen et al.
MOLECULAR CARCINOGENESIS (2015)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance
Rodrigo Jacamo et al.
BLOOD (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
M. A. Frassanito et al.
LEUKEMIA (2014)
A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells
Omar S. Aljitawi et al.
LEUKEMIA & LYMPHOMA (2014)
The bone marrow niche for haematopoietic stem cells
Sean J. Morrison et al.
NATURE (2014)
Regulation of hematopoietic stem cells by bone marrow stromal cells
Bryan A. Anthony et al.
TRENDS IN IMMUNOLOGY (2014)
Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1
James N. Arnold et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Fibroblast-Specific Protein 1/S100A4-Positive Cells Prevent Carcinoma through Collagen Production and Encapsulation of Carcinogens
Jinhua Zhang et al.
CANCER RESEARCH (2013)
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Maria Ester Bernardo et al.
CELL STEM CELL (2013)
Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels
Beatriz Sanchez-Correa et al.
CYTOKINE (2013)
Mesenchymal stromal/stem cells markers in the human bone marrow
Valeria Rasini et al.
CYTOTHERAPY (2013)
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer
Julia Tchou et al.
HUMAN PATHOLOGY (2013)
PDGFRα and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion
Sandra Pinho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: A Mechanism of Therapeutic Resistance in Pediatric AML
Edward Allan R. Sison et al.
MOLECULAR CANCER RESEARCH (2013)
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Stefan P. Glaser et al.
GENES & DEVELOPMENT (2012)
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Critical features of FAK-expressing AML bone marrow microenvironment through leukemia stem cell hijacking of mesenchymal stromal cells
M. Despeaux et al.
LEUKEMIA (2011)
Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
Faiyaz Notta et al.
SCIENCE (2011)
Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns
Michael J. Ting et al.
EXPERIMENTAL HEMATOLOGY (2010)
High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
Ruth S. Waterman et al.
PLOS ONE (2010)
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia
Pamela S. Becker et al.
BLOOD (2009)
Tocilizumab A Review of its Use in the Management of Rheumatoid Arthritis
Vicki Oldfield et al.
DRUGS (2009)
Expression of vascular cell adhesion molecule-1 indicates the differentiation potential of human bone marrow stromal cells
Kenichi Fukiage et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia
T. Matsunaga et al.
LEUKEMIA (2008)
Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease
V. Tisato et al.
LEUKEMIA (2007)
Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype
Sergej Konoplev et al.
CANCER (2007)
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C. Spoo et al.
BLOOD (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8
A Ryningen et al.
LEUKEMIA RESEARCH (2005)
In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts
N Glenjen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
M Konopleva et al.
LEUKEMIA (2002)
Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells
DC Colter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow
DC Colter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
